Fred Hutch Researchers Advance Cancer and Infectious Disease Breakthroughs

Latest findings include AI-powered cancer research, tuberculosis vaccine progress, and insights on dietary supplement psychology

Apr. 2, 2026 at 10:44pm

Got story updates? Submit your updates here. ›

A minimalist design in the style of Keith Haring where the outline of a microscope or DNA helix is defined entirely by vibrant neon lines against a deep, dark background, emphasizing the shape and energy of scientific discovery.Fred Hutch's pioneering research is illuminating new paths to cancer and infectious disease breakthroughs.San Diego Today

Fred Hutch Cancer Center researchers are making strides in cancer and infectious disease research, including testing a collaborative AI platform for accelerating cancer discoveries, developing new approaches to tuberculosis prevention, and exploring the psychology behind dietary supplement use. The center's experts are also presenting at major conferences and receiving awards for their work.

Why it matters

Fred Hutch's research aims to drive faster diagnoses, more precise treatments, and ultimately better outcomes for cancer and infectious disease patients. The center's collaborative efforts with other leading institutions, focus on rare and underserved cancers, and commitment to patient-centered care are all crucial to advancing medical breakthroughs.

The details

Key Fred Hutch research highlights include: testing a privacy-focused AI platform to speed cancer discoveries; uncovering a vulnerability in a rare childhood brain cancer; bringing together the rare cancer community; and examining how translation start-site selection can go awry in cancer. On the infectious disease front, experts are tackling tuberculosis, one of the world's deadliest infectious killers, and exploring the psychology behind dietary supplement use for cancer prevention.

  • The American Association for Cancer Research (AACR)'s Annual Meeting 2026 takes place in San Diego, Calif. from April 17-22.
  • April is the awareness month for esophageal, head and neck and testicular cancers.

The players

Cancer AI Alliance (CAIA)

A collaboration between Fred Hutch, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center and Johns Hopkins University that is testing a collaborative AI research platform to accelerate cancer research and discovery.

Christopher Lapointe, PhD

A Fred Hutch researcher who developed a lab technique to observe how proteins help ribosomes decide where to start translating strands of messenger RNA in real time, advancing knowledge of cellular mechanisms and their role in cancer and other diseases.

Paul Edlefsen, PhD, Adrienne Shapiro, MD, PhD, Jim Kublin, MD, MPH, Andrew Fiore-Gartland, PhD, and Erica Andersen-Nissen, PhD

Vaccine and immunology experts at Fred Hutch who discuss the history and challenges of preventing and treating tuberculosis, one of the world's earliest and deadliest infectious diseases.

Jonathan Bricker, PhD

A Fred Hutch researcher who discusses the psychological reasons that some individuals turn to supplements for cancer prevention, and why some go against science-based cancer prevention methods like vaccines.

Taran Gujral, PhD, and Eric Holland, MD, PhD

Researchers at Fred Hutch who have uncovered a vulnerability in tumors driven by a notorious gene fusion called ZFTA-RELA, which could lead to new treatments for rare pediatric ependymoma brain tumors.

Got photos? Submit your photos here. ›

What they’re saying

“We are closer than ever to developing a vaccine.”

— Paul Edlefsen, PhD, Adrienne Shapiro, MD, PhD, Jim Kublin, MD, MPH, Andrew Fiore-Gartland, PhD, and Erica Andersen-Nissen, PhD, Vaccine and immunology experts

What’s next

The Cancer AI Alliance (CAIA) will continue testing its collaborative AI research platform, with two projects led by Fred Hutch researchers examining AI tools for preventing skeletal problems caused by advanced cancers and making predictions about non-small cell lung cancer.

The takeaway

Fred Hutch's multifaceted research efforts, spanning cancer, infectious diseases, and the psychology of health behaviors, demonstrate the center's commitment to driving breakthroughs that improve patient outcomes and save lives. By fostering collaboration, embracing innovative technologies, and prioritizing rare and underserved conditions, Fred Hutch is positioning itself at the forefront of medical discovery.